2-Hydroxy-4-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 98%, 5g

1,5-Dimethylpyrrolidine-2,4-dione triacetate, 95.0%, 250mg

(2-(Ethoxycarbonyl)furan-3-yl)boronic acid, 95.0%, 100mg

N,N-DIISOPROPYLACRYLAMIDE, 95.0%, 250mg

Ethyl 4-methyl-2-pyrrolecarboxylate, 97.0%, 5g

Benzo[d]thiazole-4-carbaldehyde, 97.0%, 250mg

2-Fluoro-4-nitrotoluene, 98.0%, 500g

p-Tolyltetrazolium Red>95.0%(HPLC)100mg

3',4'-Dichloro-2,2-dimethylpropiophenone, 97.0%, 1g

Methyl 2-bromo-5-nitrobenzoate, 97.0%, 500g

(2-Methoxy-phenoxy)-acetic acid, 95.0%, 100g

GC capillary column ROTI®Cap-1, 30 m, 0.53 mm, 5.00 µm, 1 Piece(s)

1-Morpholino-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethanone, 98%, 250mg